The Drugs for Neglected Diseases initiative (DNDi) is an independent, not-for-profit product development partnership working to research and develop new and improved treatments for neglected diseases such as malaria, leishmaniasis, human African trypanosomiasis, and Chagas disease. With the objective to address unmet patient needs for these diseases, DNDi was established in 2003 by the Indian Council of Medical Research along with three other publicly-funded research organizations in neglected disease-endemic countries, and Institut Pasteur, and Médecins Sans Frontières.
DNDi Africa, a regional support office based in Nairobi, Kenya, supports DNDi research activities in Africa, and is based at the Kenya Medical Research Institute in Nairobi, Kenya.
In 2009, DNDi Africa will provide further information so please check back to the website soon; in the meanwhile, please visit www.dndi.org, and feel free to contact africa@dndi.org or info@dndi.org to learn more.